Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    POINT Biopharma Global In...

    NASDAQ: PNT · Real-Time Price · USD
    12.50
    0.02 (0.16%)
    At close: Dec 26, 2023, 10:00 PM

    POINT Biopharma Global Statistics

    Share Statistics

    POINT Biopharma Global has 106.57M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 106.57M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 87.47M

    Failed to Deliver (FTD) Shares

    n/a
    		 35,048

    FTD / Avg. Volume

    n/a
    		 0.91%

    Short Selling Information

    The latest short interest is 3M, so 2.82% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3M

    Short % of Shares Out

    n/a
    		 2.82%

    Short % of Float

    n/a
    		 3.32%

    Short Ratio (days to cover)

    n/a
    		 1.47

    Valuation Ratios

    The PE ratio is 7.02 and the forward PE ratio is null. POINT Biopharma Global's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 7.02

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 3.04

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.42

    P/FCF Ratio

    n/a
    		 4.04

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    POINT Biopharma Global has an Enterprise Value (EV) of 403.21M.

    EV / Sales

    n/a
    		 1.78

    EV / EBITDA

    n/a
    		 3.17

    EV / EBIT

    n/a
    		 2.2

    EV / FCF

    n/a
    		 2.36

    Financial Position

    The company has a current ratio of 6.66, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.66

    Quick Ratio

    n/a
    		 6.59

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -89.98

    Financial Efficiency

    Return on Equity is 20.19% and Return on Invested Capital is 19.55%.

    Return on Equity

    n/a
    		 20.19%

    Return on Assets

    n/a
    		 17%

    Return on Invested Capital

    n/a
    		 19.55%

    Revenue Per Employee

    n/a
    		 $1,756,430.72

    Profits Per Employee

    n/a
    		 $761,962.89

    Employee Count

    n/a
    		 129

    Asset Turnover

    n/a
    		 0.39

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 31.29M

    Effective Tax Rate

    n/a
    		 24.15%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so POINT Biopharma Global's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 13.21

    200-Day Moving Average

    n/a
    		 9.87

    Relative Strength Index (RSI)

    n/a
    		 35.38

    Average Volume (20 Days)

    n/a
    		 3,849,591

    Income Statement

    In the last 12 months, POINT Biopharma Global had revenue of 226.58M and earned 98.29M in profits. Earnings per share was 1.04.

    Revenue

    n/a
    		 226.58M

    Gross Profit

    n/a
    		 226.58M

    Operating Income

    n/a
    		 125.52M

    Net Income

    n/a
    		 98.29M

    EBITDA

    n/a
    		 127.32M

    EBIT

    n/a
    		 128.19M

    Earnings Per Share (EPS)

    n/a
    		 1.04
    Full Income Statement

    Balance Sheet

    The company has 286.43M in cash and 0 in debt, giving a net cash position of 286.43M.

    Cash & Cash Equivalents

    n/a
    		 286.43M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 39.01M

    Total Assets

    n/a
    		 477.7M

    Working Capital

    n/a
    		 314.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 183.52M and capital expenditures -12.77M, giving a free cash flow of 170.75M.

    Operating Cash Flow

    n/a
    		 183.52M

    Capital Expenditures

    n/a
    		 -12.77M

    Free Cash Flow

    n/a
    		 170.75M

    FCF Per Share

    n/a
    		 1.8
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 55.4% and 43.38%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 55.4%

    Pretax Margin

    n/a
    		 57.19%

    Profit Margin

    n/a
    		 43.38%

    EBITDA Margin

    n/a
    		 56.19%

    EBIT Margin

    n/a
    		 55.4%

    FCF Margin

    n/a
    		 75.36%

    Dividends & Yields

    PNT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 14.25%

    FCF Yield

    n/a
    		 24.76%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PNT.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 16.82

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist